Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | MAOA | P21397 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | AHR | P35869 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23174650 | 0.85 | PPARG (0.32) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL5099 | 0.84 | MAOA (0.48) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL20955824 | 0.80 | AHR (0.45) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL29487286 | 0.79 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL195537 | 0.79 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL8117592 | 0.77 | MAPT (0.39) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL654268 | 0.77 | MAOA (0.63) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL11370854 | 0.77 | MAOA (0.42) | ALDH1A1KDM4EMAPTMAOAHPGD | |
| SCHEMBL20955818 | 0.76 | MIF (0.39) | ALDH1A1KDM4EMAPTCASP7HSD17B10 | |
| SCHEMBL15667773 | 0.73 | TDP1 (0.44) | ALDH1A1KDM4EMAPTMAOAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3674290-B1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-05-22 | — | — | EP | claimed |
| US-11925106-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-03-05 | — | — | US | claimed |
| CN-117024330-A | Heterocyclic compound, composition comprising same, and organic light-emitting device comprising same | 三星电子株式会社 | 2023-11-10 | — | — | CN | claimed |
| US-20230236505-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, AND LAMINATED FILM | SAN-APRO LTD. (JP) | 2023-07-27 | — | — | US | claimed |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | claimed |
| EP-3018118-B1 | BASE GENERATOR, BASE-REACTIVE COMPOSITION CONTAINING SAID BASE GENERATOR, AND BASE GENERATION METHOD | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2023-07-05 | — | — | EP | claimed |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | claimed |
| EP-4174054-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | Samsung Electronics Co., Ltd. (KR) | 2023-05-03 | — | — | EP | claimed |
| US-11542252-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-03 | — | — | US | claimed |
| US-11360387-B2 | Silicon-containing underlayers | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2022-06-14 | — | — | US | claimed |
| WO-2007032574-A1 | ANTIREFLECTIVE HARDMASK COMPOSITION AND METHODS FOR USING SAME | CHEIL INDUSTRIES INC. (KR) | 2007-03-22 | — | — | WO | claimed |
| US-20070059635-A1 | Antireflective hardmask composition and methods for using same | CHEIL INDUSTRIES, INC. (KR) | 2007-03-15 | — | — | US | claimed |
| US-20070003863-A1 | Acid catalysts; vapor deposition; etching; photomasks; photoresists; lithography; semiconductors; integrated circuits | CHEIL INDUSTRIES, INC. (KR) | 2007-01-04 | — | — | US | claimed |
| WO-2006135136-A1 | ANTIREFLECTIVE HARDMASK COMPOSITION AND METHODS FOR USING SAME | CHEIL INDUSTRIES INC. (KR) | 2006-12-21 | — | — | WO | claimed |
| WO-2006126776-A1 | ANTIREFLECTIVE HARDMASK COMPOSITION AND METHODS FOR USING SAME | CHEIL INDUSTRIES INC. (KR) | 2006-11-30 | — | — | WO | claimed |
| US-20060269867-A1 | Antireflective hardmask composition and methods for using same | CHEIL INDUSTRIES, INC. (KR) | 2006-11-30 | — | — | US | claimed |
| WO-2006121242-A1 | ANTIREFLECTIVE HARDMASK COMPOSITION AND METHODS FOR USING SAME | CHEIL INDUSTRIES INC. (KR) | 2006-11-16 | — | — | WO | claimed |
| US-20060251990-A1 | Antireflective hardmask composition and methods for using same | CHEIL INDUSTRIES, INC. (KR) | 2006-11-09 | — | — | US | claimed |
| WO-2006056541-A1 | PROCESS FOR PREPARING ACYLPHOSPHANES AND DERIVATIVES THEREOF | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-06-01 | — | — | WO | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542252-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | ALDH1A1 172/4885KDM4E 3931/4885MAPT 1692/4885 |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CRY1, CYP1B1, CYP1A1 | ALDH1A1 40/4885KDM4E 2739/4885MAPT 1884/4885 |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | ALDH1A1 172/4885KDM4E 3931/4885MAPT 1692/4885 |
| US-11925106-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | CCNB1, CCNA1, CCNT1 | ALDH1A1 642/4885KDM4E 4280/4885MAPT 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.